AveXis Inc. (AVXS)

217.83
0.18 0.08
Prev Close 217.65
Open 217.78
Day Low/High 217.71 / 217.94
52 Wk Low/High 65.54 / 217.94
Volume 884.12K
Avg Volume 858.10K
Exchange
Shares Outstanding 36.82M
Market Cap 8.02B
EPS -7.30
Div & Yield N.A. (N.A)
AveXis To Report Third Quarter 2016 Financial And Operating Results

AveXis To Report Third Quarter 2016 Financial And Operating Results

Conference call and webcast on November 10 at 4:30 p.m. EST

AveXis Reports Interim Data From Ongoing Phase 1 Clinical Trial Of AVXS-101 In Spinal Muscular Atrophy Type 1 As Presented At The International Annual Congress Of The World Muscle Society

AveXis Reports Interim Data From Ongoing Phase 1 Clinical Trial Of AVXS-101 In Spinal Muscular Atrophy Type 1 As Presented At The International Annual Congress Of The World Muscle Society

AveXis, Inc. (NASDAQ: AVXS), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today provided an update on interim data from the...

These 7 Stocks Are Spiking on Big Volume

These 7 Stocks Are Spiking on Big Volume

Here's a technical look at how to trade several stocks rising on unusual volume.

Ionis Childhood Spine Disorder Drug Notches Pivotal Study Win, Triggers Biogen Option

Ionis Childhood Spine Disorder Drug Notches Pivotal Study Win, Triggers Biogen Option

An experimental treatment for a rare, children's spine disorder developed by Ionis achieved the primary endpoint of a late-stage clinical trial, triggering Biogen to exercise a partnership option.

Analysts' Actions -- Domino's, McDonald's, Priceline, Tesla and More

Analysts' Actions -- Domino's, McDonald's, Priceline, Tesla and More

Here are Wednesday's top research calls, including downgrades for Domino's Pizza, McDonald's and Tesla, and an upgrade for Priceline.

These 5 Stocks Are Poised for Breakouts

These 5 Stocks Are Poised for Breakouts

These stocks are setting up to trigger big breakout trades. Here's how to trade them from here.

What You Need to Know About Biotech IPOs This Year

What You Need to Know About Biotech IPOs This Year

Here's the lowdown on the biotech companies that have come public this year.

AveXis Presents Pulmonary Data From Ongoing Phase 1 Trial Of AVXS-101 In Spinal Muscular Atrophy Type 1

AveXis Presents Pulmonary Data From Ongoing Phase 1 Trial Of AVXS-101 In Spinal Muscular Atrophy Type 1

-- Richard Shell, MD, Presented Data as of April 1, 2016 at the American Thoracic Society 2016 Conference --